Research/art/teacher profile of a person
Name and surname:
doc. MUDr. Michal Chovanec, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Chovanec
I.2 - Name
Michal
I.3 - Degrees
doc. MUDr. PhD.
I.4 - Year of birth
1984
I.5 - Name of the workplace
2nd Department o Oncology
I.6 - Address of the workplace
Klenová 1, 83310, Bratislava
I.7 - Position
associate professor
I.8 - E-mail address
michal.chovanec1@gmail.com
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/25522
I.10 - Name of the study field in which a person works at the university
oncology
I.11 - ORCID iD
0000-0002-5653-2909

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Lekárska fakulta Univerzity Pavla Jozefa Šafárika
II.b - Year
2008
II.c - Study field and programme
general medicine
II.2 - Second degree of higher education
II.a - Name of the university or institution
Univerzita P. J. Šafárika v Košiciach, Lekárska fakulta
II.b - Year
2008
II.c - Study field and programme
general medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Comenius University, Faculty of Medicine
II.b - Year
2015
II.c - Study field and programme
Oncology
II.4 - Associate professor
II.a - Name of the university or institution
Comenius University, Faculty of Medicine
II.b - Year
2019
II.c - Study field and programme
oncology
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
associate professor Comenius University, Faculty of Medicine since 2015
fellow, oncologist National Cancer Institute 2008 - now
research scholar Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA 2016-2017
visiting professor Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA 2017-present

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
11th Masterclass in Clinical Oncology European School of Oncology 2011
board examination clinical oncology Comenius University, Faculty of Medicine 2013
ICRETT fellowship Union for International Cancer Control - Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA 2015
Methods in Clinical Cancer Research European Organisation for Research and Treatment of Cancer and American Association for Cancer Research - Zeist, Netherlands 2019

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
oncology general medicine I.+II. general medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
1
V.4.c - Dissertation (third degree)
4
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
4
V.4.c - Dissertation (third degree)
1
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Socially significant malignancies general medicine I.+II. general medicine

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
200
VI.1.b - Over the last six years
160
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
101
VI.1.b - Over the last six years
74
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
1991
VI.1.b - Over the last six years
1600
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
1991
VI.1.b - Over the last six years
1600
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
55
VI.1.b - Over the last six years
42
VI.2 - The most significant research/artistic/other outputs
1

Chovanec M, Cheng L. Advances in diagnosis and treatment of testicular cancer. BMJ. 2022 Nov 28;379:e070499. doi: 10.1136/bmj-2022-070499. PMID: 36442868. IF(JCR) 105,7

2

Chovanec M, Abu Zaid M, Hanna N, El-Kouri N, Einhorn LH, Albany C. Long-term toxicity of cisplatin in germ-cell tumor survivors. Ann Oncol. 2017 Nov 1;28(11):2670-2679. doi: 10.1093/annonc/mdx360. PMID: 29045502; PMCID: PMC6246726. IF (JCR) 2017=13,926

3

Chovanec M, Adra N, Abu Zaid M, Abonour R, Einhorn L. High-dose chemotherapy for relapsed testicular germ cell tumours. Nat Rev Urol. 2023 Apr;20(4):217-225. doi: 10.1038/s41585-022-00683-1. Epub 2022 Dec 7. PMID: 36477219 IF (JCR) 2023 = 12,1

4

Chovanec M, Cierna Z, Miskovska V, Machalekova K, Kalavska K, Rejlekova K, Svetlovska D, Macak D, Spanik S, Kajo K, Babal P, De Giorgi U, Mego M, Mardiak J. Systemic immune-inflammation index in germ-cell tumours. Br J Cancer. 2018 Mar 20;118(6):831-838. doi: 10.1038/bjc.2017.460. Epub 2018 Feb 27. PMID: 29485980; PMCID: PMC5877428. IF (JCR) 2018=5,416

5

Chovanec M, Lauritsen J, Bandak M, Oing C, Kier GG, Kreiberg M, Rosenvilde J, Wagner T, Bokemeyer C, Daugaard G. Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nat Rev Urol. 2021 Apr;18(4):227-245. doi: 10.1038/s41585-021-00440-w. Epub 2021 Mar 8. PMID: 33686290. IF (JCR) 2020=14,432

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Chovanec M, Cheng L. Advances in diagnosis and treatment of testicular cancer. BMJ. 2022 Nov 28;379:e070499. doi: 10.1136/bmj-2022-070499. PMID: 36442868. IF(JCR) 105,7

2

Orszaghova Z, Svetlovska D, Vasilkova L, Lesko P, Sycova-Mila Z, Obertova J, Palacka P, Rejlekova K, Remenarova V, Kalavska K, Mladosievicova B, Mardiak J, Mego M, Chovanec M. Longitudinal Assessment of Cognitive Function in Survivors of Testicular Germ Cell Tumor. Eur Urol Oncol. 2025 Apr;8(2):460-468. doi: 10.1016/j.euo.2024.12.003. Epub 2024 Dec 18. PMID: 39701870. IF (JCR) 2020= 8,3

3

Chovanec M, Lauritsen J, Bandak M, Oing C, Kier GG, Kreiberg M, Rosenvilde J, Wagner T, Bokemeyer C, Daugaard G. Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nat Rev Urol. 2021 Apr;18(4):227-245. doi: 10.1038/s41585-021-00440-w. Epub 2021 Mar 8. PMID: 33686290. IF (JCR) 2020=14,432

4

Chovanec M, Kalavska K, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Orszaghova Z, Lesko P, De Angelis V, Vasilkova L, Svetlovska D, Mladosievicova B, Mardiak J, Pastorek M, Vlkova B, Celec P, Mego M. Cognitive impairment and biomarkers of gut microbial translocation in testicular germ cell tumor survivors. Front Oncol. 2023 Mar 21;13:1146032. doi: 10.3389/fonc.2023.1146032. PMID: 37025582; PMCID: PMC10070731. IF (JCR) 6,575

5

Chovanec M, Adra N, Abu Zaid M, Abonour R, Einhorn L. High-dose chemotherapy for relapsed testicular germ cell tumours. Nat Rev Urol. 2023 Apr;20(4):217-225. doi: 10.1038/s41585-022-00683-1. Epub 2022 Dec 7. PMID: 36477219. IF (JCR) 15,3

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Chovanec M, Hanna N, Cary KC, Einhorn L, Albany C. Management of stage I testicular germ cell tumours. Nat Rev Urol. 2016 Nov;13(11):663-673. doi: 10.1038/nrurol.2016.164. Epub 2016 Sep 13. PMID: 27618772. IF (JCR) 2016=7,735 CITATION: Gilligan, T. - Lin, D.W. - Aggarwal, R. - Chism, D. - Cost, N. - Derweesh, I.H. - Emamekhoo, H. - Feldman, D.R. - Geynisman, D.M. - Hancock, S.L. - LaGrange, C. - Levine, E.G. - Longo, T. - Lowrance, W. - McGregor, B. - Monk, P. -Picus, J. - Pierorazio, P. - Rais-Bahrami, S. - Saylor, P. - Sircar, K. - Smith, D.C. - Tzou, K. - Vaena, D. - Vaughn, D. - Yamoah, K. - Yamzon, J. - Johnson-Chilla, A. - Keller, J. - Pluchino, L.A.: JNCCN Journal of the National Comprehensive CancerNetwork, vol. 17, no. 12, 2019, s. 1529-1554 - SCI ; SCOPUS

2

Chovanec M, Abu Zaid M, Hanna N, El-Kouri N, Einhorn LH, Albany C. Long-term toxicity of cisplatin in germ-cell tumor survivors. Ann Oncol. 2017 Nov 1;28(11):2670-2679. doi: 10.1093/annonc/mdx360. PMID: 29045502; PMCID: PMC6246726. IF (JCR) 2017=13,926 CITATION: Gilligan, T. - Lin, D.W. - Aggarwal, R. - Chism, D. - Cost, N. - Derweesh, I.H. - Emamekhoo, H. - Feldman, D.R. - Geynisman, D.M. - Hancock, S.L. - LaGrange, C. - Levine, E.G. - Longo, T. - Lowrance, W. - McGregor, B. - Monk, P. -Picus, J. - Pierorazio, P. - Rais-Bahrami, S. - Saylor, P. - Sircar, K. - Smith, D.C. - Tzou, K. - Vaena, D. - Vaughn, D. - Yamoah, K. - Yamzon, J. - Johnson-Chilla, A. - Keller, J. - Pluchino, L.A.: JNCCN Journal of the National Comprehensive CancerNetwork, vol. 17, no. 12, 2019, s. 1529-1554 - SCI ; SCOPUS


3

Chovanec M, Abu Zaid M, Hanna N, El-Kouri N, Einhorn LH, Albany C. Long-term toxicity of cisplatin in germ-cell tumor survivors. Ann Oncol. 2017 Nov 1;28(11):2670-2679. doi: 10.1093/annonc/mdx360. PMID: 29045502; PMCID: PMC6246726. IF (JCR) 2017=13,926 CITATION: Stephenson, A. - Eggener, S.E. - Bass, E.B. - Chelnick, D.M. - Daneshmand, S. - Feldman, D. - Gilligan, T. - Karam, J.A. - Leibovich, B. - Liauw, S.L. - Masterson, T.A. - Meeks, J.J. -Pierorazio, P.M. - Sharma, R. - Sheinfeld, J.: Journal of Urology, vol. 202, no. 2, 2019, s. 272-281 - SCI ; SCOPUS

4

Chovanec M, Vasilkova L, Setteyova L, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Kalavska K, Svetlovska D, Cingelova S, Mladosievicova B, Mardiak J, Mego M. Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors. Oncologist. 2018 May;23(5):617-623. doi: 10.1634/theoncologist.2017-0457. Epub 2018 Jan 19. PMID: 29352051; PMCID: PMC5947452. IF (JCR) 2018=5,252 CITATION: Fung, C. - Dinh, P.C. - Fossa, S.D. - Travis, L.B.: Journal of the National Comprehensive Cancer Network, vol. 17, no. 12, 2019, s. 1557-1568 -

SCI ; SCOPUS

5

Chovanec M, Cierna Z, Miskovska V, Machalekova K, Kalavska K, Rejlekova K, Svetlovska D, Macak D, Spanik S, Kajo K, Babal P, De Giorgi U, Mego M, Mardiak J. Systemic immune-inflammation index in germ-cell tumours. Br J Cancer. 2018 Mar 20;118(6):831-838. doi: 10.1038/bjc.2017.460. Epub 2018 Feb 27. PMID: 29485980; PMCID: PMC5877428. IF (JCR) 2018=5,416 CITATION: Albany, C.: British Journal of Cancer, vol. 118, no. 6, 2018, s. 761-762 - SCI ; SCOPUS

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

2016-2029 Agentúra pre podpory výskumu a vývoja - APVV-15-0086 - Identifikácia biomarkerov asociovaných s neskorou toxicitou chemoterapie u germinatívnych nádorov testis - zodpovedný riešiteľ / principal investigator

2

2019 - 2024 - Agentúra pre podpory výskumu a vývoja - APVV-19-0411 - Identifikácia a validácia biomarkerov a zodpovedných molekulárnych dráh neskorej toxicity kuratívnej liečby u germinatívnych nádorov testis - zodpovedný riešiteľ / principal investigator

3

2018 - 2021 - MZ SR 2018/39-LFUK-13.Prekonanie rezistencie voči cisplatine u refraktérnych testikulárnych nádorov zo zárodočných buniek prostredníctvom terapie nasmerovanej voči markerom nádorových kmeňových buniek - zodpovedný riešiteľ / principal investigator

4

2019 - 2021 - Grant VEGA 1/0327/19. Identifikácia úlohy mikrobiómu a imunitných molekulárnych mechanizmov kognitínych dysfunkcií následkom neskorej toxicity liečby u germinatívnych nádorov testis. Zodpovedný riešiteľ: MUDr. Chovanec Michal, PhD. - zodpovedný riešiteľ / principal investigator

5

R4 Fellowship for Excellent Researcher [09I03-03-V04-00248]; Long-term cognitive impairment and underlying molecular mechanisms in testicular germ-cell tumor survivors - zodpovedný riešiteľ/principal investigator

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
journal editor BMC Cancer, Springer Nature, IF 4,430; indexovaný v CC, Web of Science, SCOPUS, PubMed https://bmccancer.biomedcentral.com 2019 - present
journal editor Klinická onkologie, indexed in Web of Science, SCOPUS, PubMed 2024 - present

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
European School of Oncology Piazza Indipendenza, 2 6500 Bellinzona, Switzerland 2011 Masterclass in oncology
European Organisation for Research and Treatment of Cancer and American Association for Cancer Research - Zeist, Netherlands EORTC Headquarters, Brussels, Belgium 615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404 2019 Methods in Clinical Cancer Research
Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA 35 Barnhill Drive, 46202, Indianapolis, IN, USA 2015 UICC ICRETT Fellowship
Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA 535 Barnhill Drive, 46202, Indianapolis, IN, USA 2016-2017 research scholar
Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA 535 Barnhill Drive, 46202, Indianapolis, IN, USA 2017 - present visiting professor
EORTC Quality if life group Bruselles, Belgium 2023 - present European consortium for organisation of cancer research
EORTC Genitourinary cancers working group Bruselles, Belgium 2023 - present European consortium for organisation of cancer research

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

• 2014 - prize for best case repost - Klinická onkologie 2014

• 2016 - Competition of young oncologists – Foundation for cancer research, 2nd in postdoc category

• 2017 - Testicular Cancer Research in Slovakia, invited lecture, Indiana University Simon Cancer Center, Indianapolis, Indiana, USA

• 2018 - Conquer Cancer Foundation of American Society of Clinical Oncology (ASCO) Merit Award for exceptional work of young researcher, oral presentation, Genitourinary Cancers Symposium, San Francisco, California, USA

• 2018 - Competition of young oncologists – Foundation for cancer research, 1st in postdoc category

• 2018 - The Union for International Cancer Control (UICC) – selected for case study: Fighting Testicular Cancer in Slovakia Through Clinical and Translational studies – Spotlight on Quality Treatment and Care by Michal Chovanec, https://www.uicc.org/resources/case-study-fighting-testicular-cancer-slovakia-through- clinical-and-translational-research

• 2018 - Immune Mechanisms and Possible Immune Therapy in Testicular Germ Cell Tumours – Invited Lecture, 9th Copenhagen Workshop on Testicular Germ Cell Cancer, Kodaň, Dánsko

• 2018 - Personality of science and technology up to 35 years old in 2018, award of Ministry of education, science, reseatch and sport of Slovak Republic

• 2024 - European Testicular Tumor Workshop, Prague - organising committee

• 2025 - Therapeutiv options in testis cancer therapies and their late consequences - Vyzvaná prednáška, ASA/ICA annual meeting of American and International Society of Andrology, Washington D.C., USA

Date of last update
2025-04-11